Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide-38 inhibit IL-10 production in murine T lymphocytes

Journal of Immunology

Volumn 156, Issue 11, 1996, Pages 4128-4136

  Martinez, Carmen ^b   Delgado, Mario ^b   Gomariz, Rosa P ^b   Ganea, Doina ^a  

^a RUTGERS UNIVERSITY   (United States)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CYCLIC AMP; CYTOKINE; FORSKOLIN; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; INTERLEUKIN 10; INTERLEUKIN 2; MESSENGER RNA; NEUROPEPTIDE; T LYMPHOCYTE RECEPTOR; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SPLEEN CELL; T LYMPHOCYTE; THYMOCYTE;

ANIMALS; BASE SEQUENCE; CD4-POSITIVE T-LYMPHOCYTES; CYCLIC AMP; DNA PRIMERS; FEMALE; INTERLEUKIN-10; INTERLEUKIN-2; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; NEUROPEPTIDES; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RNA, MESSENGER; SIGNAL TRANSDUCTION; SPLEEN; T-LYMPHOCYTES; TRANSCRIPTION, GENETIC; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0029935847     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Moore, T. C., C. H. Spruck, and S. I. Said. 1988. Depression of lymphocyte traffic in sheep by VIP. Immunology 64:475.
2. Robichon, A., S. P. Sreedharan, J. Yang, R. S. Shames, E. C. Gronroos, P. P. J. Cheng, and E. J. Goetzl. 1993. Induction of aggregation of Raji human B cells by VIP. Immunology 79:574.
3. De la Fuente, M., M. Delgado, M. DelRio, E. Garrido, J. Leceta, A. Hernanz, and R. P. Gomariz. 1994. VIP modulation of adherence and mobility in rat peritoneal lymphocytes and macrophages. Peptides 15:1157.
4. Ottaway, C. A., and G. R. Greenberg. 1984. Interaction of VIP with mouse lymphocytes. J. Immunol. 132:417.
5. Krco, T. J., A. Gores, and V. L. W. Go. 1986. Gastrointestinal regulatory peptides modulate in vitro immune reactions of mouse lymphoid cells. Clin. Immunol. Immunopathol. 39:308.
6. Ottaway, C. A. 1987. Selective effects of VIP on the mitogenic response of murine T cells. Immunology 62:291.
7. Boudard, F., and M. Bastide. 1991. Inhibition of mouse T cell proliferation by CGRP and VIP. J. Neurosci. Res. 29:29.
8. Tang, S. C., H. Braunsteiner, and C. J. Wiedermann. 1992. Regulation of human T lymphoblast growth by sensory neuropeptides: augmentation of cholecystokinin-induced inhibition of Molt-4 proliferation by somatostatin and vasoactive intestinal peptide. Immunol. Lett. 34:237.
9. Xin, Z., H. Tang, and D. Ganea. 1994. VIP inhibits IL-2 and IL-4 production in murine thymocytes activated via the TCR/CD3 complex. J. Neuroimmunol. 54: 59.
10. Stanitz, A. M., D. Befus, and J. Bienenstock. 1986. Differential effects of vasoactive intestinal peptide, substance P and somatostatin on Ig synthesis and proliferation by lymphocytes from Peyer's patches, mesenteric lymph nodes and spleen. J. Immunol. 136:152.
11. Rola-Pleszczynski, M., D. Bolduc, and S. St-Pierre. 1985. The effects of VIP on NK function. J. Immunol. 135:4078.
12. Wiik, P. 1989. VIP inhibits the respiratory burst in human monocytes by a cAMP-mediated mechanism. Regul. Pept. 25:187.
13. DeLa Fuente, M., M. Delgado, M. del Rio, C. Martinez, A. Hernanz, and R. P. Gomariz. 1993. Stimulation by VIP of phagocytic function in rat macrophages. Involvement of PKC activity. Regul. Pept. 48:345.
14. Ichinose, M., M. Sawada, and T. Maeno. 1994. Inhibitory effect of VIP on phagocytosis in mouse peritoneal macrophages. Regul. Pept. 54:457.
15. Beed, E. A., M. S. O'Dorisio, T. M. O'Dorisio, and T. S. Gaginella. 1983. Demonstration of a functional receptor for VIP on Molt 4b T lymphoblasts. Regul. Pept. 6:1.
16. Finch, R. J., S. P. Sreedharan, and E. J. Goetzl. 1989. High affinity receptors for VIP on human myeloma cells. J. Immunol. 142:1977.
17. O'Dorisio, M. S., B. T. Shannon, D. J. Fleishman, and L. B. Campolito. 1989. Identification of high affinity receptors for VIP on human lymphocytes of the B lineage. J. Immunol. 142:3533.
18. Ottaway, C. A., T. E. Lay, and G. R. Greenberg. 1990. High affinity specific binding of VIP to human circulating T cells, B cells and large granular lymphocytes. J. Neuroimmunol. 29:149.
19. Blum, A. M., R. Mathew, G. A. Cook, A. Metwali, R. Felman, and J. V. Weinstock. 1992. Murine mucosal T cells have VIP receptors functionally distinct from those on epithelial cells. J. Neuroimmunol. 39:101.
20. Cheng, P. P. J., S. P. Sreedharan, J. L. Kishiyama, and E. J. Goetzl. 1993. The SKW 6.4 line of human B lymphocytes specifically binds and responds to VIP. Immunology 79:64.
21. Calvo, J. J., M. L. Montilla, J. M. Guerrero, and J. J. Segura. 1994. Expression of VIP receptors in mouse peritoneal macrophages. J. Neuroimmunol. 50:85.
22. Ottaway, C. A. 1992. Insertion and internalization of VIP receptors in murine CD4 T lymphocytes. Regul. Pept. 41:49.
23. Ishihara, T., R. Shigemoto, K. Mori, K. Takahashi, and S. Nagata. 1992. Functional expression and tissue distribution of a novel receptor for VIP. Neuron 8:811.
24. Sreedharan, S. P., D. R. Patel, J. X. Huang, and E. J. Goetzl. 1993. Cloning and functional expression of a human VIP receptor. Biochem. Biophys. Res. Commun. 193:546.
25. Lutz, E. M., W. J. Sheward, K. M. West, J. A. Morrow, G. Fink, and A. J. Harmar. 1993. The VIP2 receptor: molecular characterization of a cDNA encoding a novel receptor for vasoactive intestinal peptide. FEBS 334:3.
26. Inagaki, N., H. Yoshida, M. Mizuta, N. Mizuno, Y. Fujii, T. Gonoi, J. Miyazaki, and S. Susumu. 1994. Cloning and functional characterization of a third PACAP receptor subtype expressed in insulin-secreting cells. Proc. Natl. Acad. Sci. USA 91:2679.
27. Svoboda, M., M. Tastenoy, J. Van Rampelbergh, J. F. Goossens, P. De Neef, M. Waelbroeck, and P. Robberecht. 1994. Molecular cloning and functional characterization of a human VIP receptor from SUP-T1 lymphoblasts. Biochem. Biophys. Res. Commun. 205:1617.
28. Gomariz, R. P., E. Garrido, J. Leceta, C. Martinez, R. Abalo, and M. Delgado. 1994. Gene expression of VIP receptor in rat lymphocytes. Biochem. Biophys. Res. Commun. 203:1599.
29. Mathew, R. C., G. A. Cook, A. M. Blum, A. Metwali, R. Felman, and J. V. Weinstock. 1992. VIP stimulates T lymphocytes to release IL-5 in murine Schistosoma mansoni infection. J. Immunol. 148:3572.
30. Ganea, D., and L. Sun. 1993. VIP downregulates the expression of IL-2 but not of IFNγ from stimulated murine T lymphocytes. J. Neuroimmunol. 47:147.
31. Nio, D. A., R. N. Moylan, and J. K. Roche. 1993. Modulation of T lymphocyte function by neuropeptides. J. Immunol. 150:5281.
32. Sun, L., and D. Ganea. 1993. VIP inhibits IL-2 and IL-4 production through different mechanisms in T cells activated via the TCR/CD3 complex. J. Neuroimmunol. 48:59.
33. Tang, H., A. Welton, and D. Ganea. 1995. Neuropeptide regulation of cytokine expression: effects of VIP and Ro 25-1553, a cyclic VIP analog on IL-2, IL-4 and IFNγ production by murine lymphocytes. J. Interferon Cytokine Res. 15:993.
34. Howard, M., and A. O'Garra. 1992. Biological properties of interleukin 10. Immunol. Today 13:198.
35. Moore, K. W., A. O'Garra, R. deWaal Malefyr, P. Vieira, and T. R. Mosmann. 1993. Interleukin 10. Annu. Rev. Immunol. 11:165.
36. Rady, P. L., E. M. Smith, P. Cadet, M. R. Opp, S. K. Tyring, and T. K. Hughes, Jr. 1995. Presence of IL-10 transcripts in human pituitary and hypothalamus. Cell. Mol. Neurobiol. 15:289.
37. Greenberger, M. J., R. M. Strieter, S. L. Kunkel, J. M. Danforth, R. E. Goodman, and T. J. Standiford. 1995. Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumonia. J. Immunol. 155:722.
38. Arimura, A. 1992. Pituitary adenylate cyclase activating polypeptide (PACAP): discovery and current status of research. Regul. Pept. 37:287.
39. Usdin, T. B., T. I. Bonner, and E. Mezey. 1994. Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions. Endocrinology 135:2662.
40. Delgado, M., M. De La Fuente, C. Martinez, and R. P. Gomariz. 1995. PACAP-27 and PACAP-38 inhibit the mobility of murine thymocytes and splenic lymphocytes: comparison with VIP and implication of cAMP. J. Neuroimmunol. in press.
41. Houssian, F. A., L. Schandene, M. Stevens, C. Cambiaso, M. Goldman, J. Van Snick, and J. C. Renauld. 1995. A cascade of cytokines is responsible for IL-9 expression in human T cells. J. Immunol. 154:2624.
42. Fiorentino, D. F., M. W. Bond, and T. R. Mosmann. 1989. Two types of mouse T helper cells. IV. TH2 clones secrete a factor that inhibits cytokine production by TH1 clones. J. Exp. Med. 170:2081.
43. Fiorentino, D. F., A. Zlotnik, P. Vieira, T. R. Mosmann, M. Howard, K. W. Moore, and A. O'Garra. 1991. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by ThI cells. J. Immunol. 146:3444.
44. O'Garra, A., G. Stapleton, V. Dhar, M. Pearce, J. Schumacher, H. Rugo, D. Barbis, A. Stall, J. Cupp, K. W. Moore, P. Vieira, T. R. Mosmann, A. Whitmore, L. Arnold, G. Haughton, and M. Howard. 1990. Production of cytokines by mouse B cells: B lymphomas and normal B cells produce IL-10. Int. Immunol. 2:821.
45. MacNeil, I. A., T. Suda, K. W. Moore, T. R. Mosmann, and A. Zlotnik. 1990. IL-10: a novel growth factor for mature and immature T cells. J. Immunol. 145: 4167.
46. + B clones. Ann. NY Acad. Sci. 651: 551.
47. Christophe, J. 1993. Type I receptors for PACAP (a neuropeptide even more important than VIP?). Biochim. Biophys. Acta 1154:183.
48. O'Dorisio, M. S., N. Hermina, S. P. Balcerzak, and T. M. O'Dorisio. 1981. Vasoactive intestinal polypeptide stimulation of adenylate cyclase in purified human leukocytes. J. Immunol. 127:3533.
49. O'Dorisio, M. S., C. L. Wood, D. Wenger and L. M. Vassalo. 1985. Cyclic AMP-dependent protein kinase in MOLT-4B lymphoblasts: identification by photoaffinity labeling and activation in intact cells by vasoactive intestinal peptide (VIP) and peptide histidine isoleucine (PHI). J. Immunol. 134:4078.
50. Robberecht, P., J. Abello, C. Damien, P. De Neef, E. Vervisch, R. Hooghe, and J. Christophe. 1989. Variable stimulation of adenylate cyclase activity by vasoactive intestinal-like peptide and β-adrenergic agonist in murine T-cell lymphomas of immature, helper, and cytotoxic types. Immunobiology 179:422.
51. Segura, J. J., J. M. Guerrero, R. Goberna, and J. R. Calvo. 1992. Stimulatory effect of vasoactive intestinal peptide (VIP) on cyclic AMP production in rat peritoneal macrophages. Regul. Pept. 37:195.
52. Novak, T. J., and E. V. Rothenberg. 1990. cAMP inhibits induction of interleukin 2 but not of interleukin 4 in T cells. Proc. Natl. Acad. Sci. USA 87:9353.
53. Anastassiou, E. D., F. Paliogianni, J. P. Balow, H. Yamada, and D. T. Boumpas. 1992. Prostaglandin E2 and other cyclic AMP-elevating agents modulate IL-2 and IL-2Rα gene expression at multiple levels. J. Immunol. 148:2845.
54. Zorn, N., and D. H. Russell. 1990. VIP activation of nuclear protein kinase C in purified nuclei of rat splenocytes. Biochem. Pharmacol. 40:2689.
55. Olah, Z., C. Lahel, W. B. Anderson, D. E. Brenneman, and D. Von Agoston. 1994. Subnanomolar concentration of VIP induces the nuclear translocation of protein kinase C in neonatal rat cortical astrocytes. J. Neurosci. Res. 39:355.
56. Platzer, C., C. Meisel, K. Vogt, M. Platzer, and H. D. Volk. 1995. Upregulation of monocytic IL-10 by TNFα and cAMP-elevating drugs. Int. Immunol. 7:517.